Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases

Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102151. doi: 10.1016/j.dsx.2021.05.024. Epub 2021 May 25.

Authors

Abha Mishra¹, Amerta Ghosh², Koel Dutta¹, Kanika Tyagi¹, Anoop Misra¹

Affiliations

¹ Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, B-16, Chirag Enclave, New Delhi, India.
² Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology, B-16, Chirag Enclave, New Delhi, India. Electronic address: dramritaghosh@outlook.com.

No abstract available

Keywords: Covid vaccine; Covid-19; Type 2 diabetes.

Publication types

Case Reports

MeSH terms

Aged
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects*
ChAdOx1 nCoV-19
Diabetes Mellitus, Type 2 / drug therapy
Diabetes Mellitus, Type 2 / metabolism*
Disease Progression
Female
Humans
Hyperglycemia / chemically induced*
Male
Middle Aged
SARS-CoV-2

Substances

COVID-19 Vaccines
ChAdOx1 nCoV-19